Status:
ACTIVE_NOT_RECRUITING
Comparing Targets of Expressive Writing
Lead Sponsor:
Trustees of Princeton University
Conditions:
Healthy
Anxiety
Eligibility:
All Genders
18-25 years
Phase:
NA
Brief Summary
Expressive writing involves writing about one's deepest thoughts and feelings surrounding an emotional event. The current literature on the efficacy of expressive writing is mixed and warrants further...
Eligibility Criteria
Inclusion
- US-based
- Fluent English
- Combined GAD-7 and PHQ-8 score of ≥ 5
Exclusion
- "Completion" of a writing session requires participants to spend at least 15 minutes on the writing page. We will monitor completion of the daily writing exercise, and will contact participants who miss or spend less than 15 minutes on the exercise. Participants who fail to complete 3 consecutive daily writing sessions will be deemed non-compliant, removed from the study, and paid a prorated amount for the tasks they have completed in the study.
Key Trial Info
Start Date :
November 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
159 Patients enrolled
Trial Details
Trial ID
NCT06130020
Start Date
November 10 2023
End Date
September 1 2025
Last Update
July 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peretsman Scully Hall
Princeton, New Jersey, United States, 08540